This course discusses the profound and lasting impact of the pandemic on the healthcare system. The first part of the course addresses the clinical aspects of COVID-19 along with case discussions about the manner in which it has fundamentally altered healthcare delivery. The general principles of medical technology development (drugs and devices) serve as a foundation for learning specific to COVID-19, including the development of vaccines, monoclonal antibodies, and diagnostics. The effect of COVID-19 on the operational aspects of biopharmaceutical and medical device companies is also explored, with a focus on manufacturing and supply chain. Finally, the critical role that public health organizations, including the FDA and CDC, have played in the evolution of the pandemic is discussed. In addition to Purdue faculty, instructors include industry and government experts.
For potential corporate partnerships, please contact Diana Hancock at firstname.lastname@example.org.